a)<p>The 7E11c mAb recognizes an intracellular PSMA epitope and is therefore used as a further control of the experiment described.</p>b)<p>Results of gel densitometry are expressed as the ratio±SEM of activated/total protein as evaluated by measuring the respective areas.</p>c)<p>Statistical significance is reported with respect to the “No treatment” data.</p>d)<p>ns = not significant.</p>e)<p>nd = not determined.</p
<p>A) EPCs were treated with RAD and/or CLC alone or in combination. Thereafter, both the activity a...
<p>CLEC9A in THP-1 cells was knocked down using lentiviral-based shRNA. After treating with heat-kil...
<p> (A) ERK1/2 is phosphorylated in response to both, DPBA and FCS. A7r5 cells stimulated with eithe...
<p>IL-6 (panel A) and CCL5 (panel B): production by LNCaP cells left untreated (open bars), stimulat...
<p>(A) LNCaP cells were activated by antibody-induced cross-linking of PSMA at 37°C or 4°C. Subseque...
<p>(A) LNCaP cells were activated by antibody-induced cross-linking of PSMA for different time perio...
<p>Panel <b>A</b> shows inhibition of light chain (LC)-stimulated phosphorylation of ERK ½, and pane...
<p>(<b>A</b>) Cell surface binding of the therapeutic fusion protein 390 scFv-TM to REN-muP cells wa...
<p>Panel A: representative flow cytometry of LNCaP cells stained with anti-PSMA or with J591 mAb. Co...
<p>PBMC were incubated with either EV71 antigen or medium as indicated in Materials and Methods. Up-...
<p>(<b>A</b>) and (<b>B</b>) Western blot analysis of NCAM, STX, PST and PSA-NCAM expression, using ...
<p>16HBE14o- cells were grown on 6-well plates for 9–10 days until confluent and were serum starved ...
<p>(A) Binding specificity of 4 human anti-prM mAbs including 2 CR (DVB59.3 and DVB18.5) and 2 sCR (...
<div><p>The rate change of EpCAM-positive cells in 5000 cells with overexpression of caRheb or contr...
<p>(A) Representative photomicrographs and (B) Quantification of R1c mAb induced neuronal activity a...
<p>A) EPCs were treated with RAD and/or CLC alone or in combination. Thereafter, both the activity a...
<p>CLEC9A in THP-1 cells was knocked down using lentiviral-based shRNA. After treating with heat-kil...
<p> (A) ERK1/2 is phosphorylated in response to both, DPBA and FCS. A7r5 cells stimulated with eithe...
<p>IL-6 (panel A) and CCL5 (panel B): production by LNCaP cells left untreated (open bars), stimulat...
<p>(A) LNCaP cells were activated by antibody-induced cross-linking of PSMA at 37°C or 4°C. Subseque...
<p>(A) LNCaP cells were activated by antibody-induced cross-linking of PSMA for different time perio...
<p>Panel <b>A</b> shows inhibition of light chain (LC)-stimulated phosphorylation of ERK ½, and pane...
<p>(<b>A</b>) Cell surface binding of the therapeutic fusion protein 390 scFv-TM to REN-muP cells wa...
<p>Panel A: representative flow cytometry of LNCaP cells stained with anti-PSMA or with J591 mAb. Co...
<p>PBMC were incubated with either EV71 antigen or medium as indicated in Materials and Methods. Up-...
<p>(<b>A</b>) and (<b>B</b>) Western blot analysis of NCAM, STX, PST and PSA-NCAM expression, using ...
<p>16HBE14o- cells were grown on 6-well plates for 9–10 days until confluent and were serum starved ...
<p>(A) Binding specificity of 4 human anti-prM mAbs including 2 CR (DVB59.3 and DVB18.5) and 2 sCR (...
<div><p>The rate change of EpCAM-positive cells in 5000 cells with overexpression of caRheb or contr...
<p>(A) Representative photomicrographs and (B) Quantification of R1c mAb induced neuronal activity a...
<p>A) EPCs were treated with RAD and/or CLC alone or in combination. Thereafter, both the activity a...
<p>CLEC9A in THP-1 cells was knocked down using lentiviral-based shRNA. After treating with heat-kil...
<p> (A) ERK1/2 is phosphorylated in response to both, DPBA and FCS. A7r5 cells stimulated with eithe...